BioCentury
ARTICLE | Clinical News

Bivigam 10% human immune globulin regulatory update

January 7, 2013 8:00 AM UTC

On Dec. 20, Biotest said FDA approved a BLA from Biotest's Biotest Pharmaceuticals Corp. subsidiary for IV Bivigam 10% human immune globulin to treat primary immune deficiency disorders. The company p...